title: Pharmacotherapy for allergic rhinitis.
abstract: Allergic rhinitis affects millions of Americans and the numbers continue to increase. Fortunately, there exists a wide array of pharmacotherapeutic options with relatively safe side effect profiles for the management of the varying subtypes. Additionally, there are newer agents on the horizon. The efficacies of intranasal corticosteroids, antihistamines, combination topical therapy, leukotriene inhibitors, mast cell stabilizers, anticholinergics, mucolytics, decongestants, and anti-IgE are reviewed.
authors.affiliation: Johns Hopkins Department of Otolaryngology-Head and Neck Surgery, Baltimore, MD 21287, USA. tamelvin@gmail.com
authors.forename: Thuy-Anh N
authors.initials: TA
authors.lastname: Melvin
authors.forename: Alpen A
authors.initials: AA
authors.lastname: Patel
mesh_terms: D000281:Administration, Intranasal; D018926:Anti-Allergic Agents / Q000627:therapeutic use; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D004205:Cromolyn Sodium / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005100:Expectorants / Q000627:therapeutic use; D005938:Glucocorticoids / Q000008:administration & dosage; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D007073:Immunoglobulin E; D020024:Leukotriene Antagonists / Q000627:therapeutic use; D014663:Nasal Decongestants / Q000627:therapeutic use; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*
chemical_list: D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D018680:Cholinergic Antagonists; D005100:Expectorants; D005938:Glucocorticoids; D006633:Histamine Antagonists; D020024:Leukotriene Antagonists; D014663:Nasal Decongestants; C026408:anti-IgE antibodies; D007073:Immunoglobulin E; D004205:Cromolyn Sodium